Novel Drug Delivery Systems for Cancer Therapy Market - Global Outlook and Forecast 2021-2027

Novel Drug Delivery Systems for Cancer Therapy Market - Global Outlook and Forecast 2021-2027

Report Code: KNJ687480 | No. of Pages: 105 | Category: Pharmaceuticals and Healthcare
Publisher: Market Monitor Global | Date of Publish: Apr-2021
This report contains market size and forecasts of Novel Drug Delivery Systems for Cancer Therapy in Global, including the following market information:
Global Novel Drug Delivery Systems for Cancer Therapy Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global top five companies in 2020 (%)
The global Novel Drug Delivery Systems for Cancer Therapy market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Novel Drug Delivery Systems for Cancer Therapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Novel Drug Delivery Systems for Cancer Therapy Market, By Type, 2016-2021, 2022-2027 ($ millions)
Global Novel Drug Delivery Systems for Cancer Therapy Market Segment Percentages, By Type, 2020 (%)
Embolization Particles – Drug Eluting Beads
Polyvinyl Alcohol Particles
Microspheres
Gelatin-Based Embolization Devices
Selective Internal Radiation Therapy
Holmium-Based Microspheres
Liquid Embolics – Onyx
Other

China Novel Drug Delivery Systems for Cancer Therapy Market, By Application, 2016-2021, 2022-2027 ($ millions)
China Novel Drug Delivery Systems for Cancer Therapy Market Segment Percentages, By Application, 2020 (%)
Hospitals
Clinics
Others

Global Novel Drug Delivery Systems for Cancer Therapy Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)
Global Novel Drug Delivery Systems for Cancer Therapy Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa

Competitor Analysis
The report also provides analysis of leading market participants including:
Total Novel Drug Delivery Systems for Cancer Therapy Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)
Total Novel Drug Delivery Systems for Cancer Therapy Market Competitors Revenues Share in Global, by Players 2020 (%)
Further, the report presents profiles of competitors in the market, including the following:
Advanced Medical Isotope Corporation
Bind Therapeutics
Boston Scientific Corporation
BTG plc
CeloNova BioSciences, Inc.
Cook Medical, Inc.
Cospheric LLC
Covidien, plc
Eckert & Ziegler BEBIG
EmboMedics, Inc.
Kobo Products, Inc.
Merit Medical Systems, Inc.
Mo-Sci Corporation
Nanobiotix
Polysciences, Inc.
Sirtex Medical, Inc.
Terumo Corporation
1 Introduction to Research & Analysis Reports
    1.1 Novel Drug Delivery Systems for Cancer Therapy Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Novel Drug Delivery Systems for Cancer Therapy Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Novel Drug Delivery Systems for Cancer Therapy Overall Market Size
    2.1 Global Novel Drug Delivery Systems for Cancer Therapy Market Size: 2021 VS 2027
    2.2 Global Novel Drug Delivery Systems for Cancer Therapy Market Size, Prospects & Forecasts: 2016-2027
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Novel Drug Delivery Systems for Cancer Therapy Players in Global Market
    3.2 Top Global Novel Drug Delivery Systems for Cancer Therapy Companies Ranked by Revenue
    3.3 Global Novel Drug Delivery Systems for Cancer Therapy Revenue by Companies
    3.4 Top 3 and Top 5 Novel Drug Delivery Systems for Cancer Therapy Companies in Global Market, by Revenue in 2020
    3.5 Global Companies Novel Drug Delivery Systems for Cancer Therapy Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Novel Drug Delivery Systems for Cancer Therapy Players in Global Market
        3.6.1 List of Global Tier 1 Novel Drug Delivery Systems for Cancer Therapy Companies
        3.6.2 List of Global Tier 2 and Tier 3 Novel Drug Delivery Systems for Cancer Therapy Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 By Type - Global Novel Drug Delivery Systems for Cancer Therapy Market Size Markets, 2021 & 2027
        4.1.2 Embolization Particles – Drug Eluting Beads
        4.1.3 Polyvinyl Alcohol Particles
        4.1.4 Microspheres
        4.1.5 Gelatin-Based Embolization Devices
        4.1.6 Selective Internal Radiation Therapy
        4.1.7 Holmium-Based Microspheres
        4.1.8 Liquid Embolics – Onyx
        4.1.9 Other
    4.2 By Type - Global Novel Drug Delivery Systems for Cancer Therapy Revenue & Forecasts
        4.2.1 By Type - Global Novel Drug Delivery Systems for Cancer Therapy Revenue, 2016-2021
        4.2.2 By Type - Global Novel Drug Delivery Systems for Cancer Therapy Revenue, 2022-2027
        4.2.3 By Type - Global Novel Drug Delivery Systems for Cancer Therapy Revenue Market Share, 2016-2027
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Novel Drug Delivery Systems for Cancer Therapy Market Size, 2021 & 2027
        5.1.2 Hospitals
        5.1.3 Clinics
        5.1.4 Others
    5.2 By Application - Global Novel Drug Delivery Systems for Cancer Therapy Revenue & Forecasts
        5.2.1 By Application - Global Novel Drug Delivery Systems for Cancer Therapy Revenue, 2016-2021
        5.2.2 By Application - Global Novel Drug Delivery Systems for Cancer Therapy Revenue, 2022-2027
        5.2.3 By Application - Global Novel Drug Delivery Systems for Cancer Therapy Revenue Market Share, 2016-2027
6 Sights by Region
    6.1 By Region - Global Novel Drug Delivery Systems for Cancer Therapy Market Size, 2021 & 2027
    6.2 By Region - Global Novel Drug Delivery Systems for Cancer Therapy Revenue & Forecasts
        6.2.1 By Region - Global Novel Drug Delivery Systems for Cancer Therapy Revenue, 2016-2021
        6.2.2 By Region - Global Novel Drug Delivery Systems for Cancer Therapy Revenue, 2022-2027
        6.2.3 By Region - Global Novel Drug Delivery Systems for Cancer Therapy Revenue Market Share, 2016-2027
    6.3 North America
        6.3.1 By Country - North America Novel Drug Delivery Systems for Cancer Therapy Revenue, 2016-2027
        6.3.2 US Novel Drug Delivery Systems for Cancer Therapy Market Size, 2016-2027
        6.3.3 Canada Novel Drug Delivery Systems for Cancer Therapy Market Size, 2016-2027
        6.3.4 Mexico Novel Drug Delivery Systems for Cancer Therapy Market Size, 2016-2027
    6.4 Europe
        6.4.1 By Country - Europe Novel Drug Delivery Systems for Cancer Therapy Revenue, 2016-2027
        6.4.2 Germany Novel Drug Delivery Systems for Cancer Therapy Market Size, 2016-2027
        6.4.3 France Novel Drug Delivery Systems for Cancer Therapy Market Size, 2016-2027
        6.4.4 U.K. Novel Drug Delivery Systems for Cancer Therapy Market Size, 2016-2027
        6.4.5 Italy Novel Drug Delivery Systems for Cancer Therapy Market Size, 2016-2027
        6.4.6 Russia Novel Drug Delivery Systems for Cancer Therapy Market Size, 2016-2027
        6.4.7 Nordic Countries Novel Drug Delivery Systems for Cancer Therapy Market Size, 2016-2027
        6.4.8 Benelux Novel Drug Delivery Systems for Cancer Therapy Market Size, 2016-2027
    6.5 Asia
        6.5.1 By Region - Asia Novel Drug Delivery Systems for Cancer Therapy Revenue, 2016-2027
        6.5.2 China Novel Drug Delivery Systems for Cancer Therapy Market Size, 2016-2027
        6.5.3 Japan Novel Drug Delivery Systems for Cancer Therapy Market Size, 2016-2027
        6.5.4 South Korea Novel Drug Delivery Systems for Cancer Therapy Market Size, 2016-2027
        6.5.5 Southeast Asia Novel Drug Delivery Systems for Cancer Therapy Market Size, 2016-2027
        6.5.6 India Novel Drug Delivery Systems for Cancer Therapy Market Size, 2016-2027
    6.6 South America
        6.6.1 By Country - South America Novel Drug Delivery Systems for Cancer Therapy Revenue, 2016-2027
        6.6.2 Brazil Novel Drug Delivery Systems for Cancer Therapy Market Size, 2016-2027
        6.6.3 Argentina Novel Drug Delivery Systems for Cancer Therapy Market Size, 2016-2027
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Novel Drug Delivery Systems for Cancer Therapy Revenue, 2016-2027
        6.7.2 Turkey Novel Drug Delivery Systems for Cancer Therapy Market Size, 2016-2027
        6.7.3 Israel Novel Drug Delivery Systems for Cancer Therapy Market Size, 2016-2027
        6.7.4 Saudi Arabia Novel Drug Delivery Systems for Cancer Therapy Market Size, 2016-2027
        6.7.5 UAE Novel Drug Delivery Systems for Cancer Therapy Market Size, 2016-2027
7 Players Profiles
    7.1 Advanced Medical Isotope Corporation
        7.1.1 Advanced Medical Isotope Corporation Corporate Summary
        7.1.2 Advanced Medical Isotope Corporation Business Overview
        7.1.3 Advanced Medical Isotope Corporation Novel Drug Delivery Systems for Cancer Therapy Major Product Offerings
        7.1.4 Advanced Medical Isotope Corporation Novel Drug Delivery Systems for Cancer Therapy Revenue in Global (2016-2021)
        7.1.5 Advanced Medical Isotope Corporation Key News
    7.2 Bind Therapeutics
        7.2.1 Bind Therapeutics Corporate Summary
        7.2.2 Bind Therapeutics Business Overview
        7.2.3 Bind Therapeutics Novel Drug Delivery Systems for Cancer Therapy Major Product Offerings
        7.2.4 Bind Therapeutics Novel Drug Delivery Systems for Cancer Therapy Revenue in Global (2016-2021)
        7.2.5 Bind Therapeutics Key News
    7.3 Boston Scientific Corporation
        7.3.1 Boston Scientific Corporation Corporate Summary
        7.3.2 Boston Scientific Corporation Business Overview
        7.3.3 Boston Scientific Corporation Novel Drug Delivery Systems for Cancer Therapy Major Product Offerings
        7.3.4 Boston Scientific Corporation Novel Drug Delivery Systems for Cancer Therapy Revenue in Global (2016-2021)
        7.3.5 Boston Scientific Corporation Key News
    7.4 BTG plc
        7.4.1 BTG plc Corporate Summary
        7.4.2 BTG plc Business Overview
        7.4.3 BTG plc Novel Drug Delivery Systems for Cancer Therapy Major Product Offerings
        7.4.4 BTG plc Novel Drug Delivery Systems for Cancer Therapy Revenue in Global (2016-2021)
        7.4.5 BTG plc Key News
    7.5 CeloNova BioSciences, Inc.
        7.5.1 CeloNova BioSciences, Inc. Corporate Summary
        7.5.2 CeloNova BioSciences, Inc. Business Overview
        7.5.3 CeloNova BioSciences, Inc. Novel Drug Delivery Systems for Cancer Therapy Major Product Offerings
        7.5.4 CeloNova BioSciences, Inc. Novel Drug Delivery Systems for Cancer Therapy Revenue in Global (2016-2021)
        7.5.5 CeloNova BioSciences, Inc. Key News
    7.6 Cook Medical, Inc.
        7.6.1 Cook Medical, Inc. Corporate Summary
        7.6.2 Cook Medical, Inc. Business Overview
        7.6.3 Cook Medical, Inc. Novel Drug Delivery Systems for Cancer Therapy Major Product Offerings
        7.6.4 Cook Medical, Inc. Novel Drug Delivery Systems for Cancer Therapy Revenue in Global (2016-2021)
        7.6.5 Cook Medical, Inc. Key News
    7.7 Cospheric LLC
        7.7.1 Cospheric LLC Corporate Summary
        7.7.2 Cospheric LLC Business Overview
        7.7.3 Cospheric LLC Novel Drug Delivery Systems for Cancer Therapy Major Product Offerings
        7.4.4 Cospheric LLC Novel Drug Delivery Systems for Cancer Therapy Revenue in Global (2016-2021)
        7.7.5 Cospheric LLC Key News
    7.8 Covidien, plc
        7.8.1 Covidien, plc Corporate Summary
        7.8.2 Covidien, plc Business Overview
        7.8.3 Covidien, plc Novel Drug Delivery Systems for Cancer Therapy Major Product Offerings
        7.8.4 Covidien, plc Novel Drug Delivery Systems for Cancer Therapy Revenue in Global (2016-2021)
        7.8.5 Covidien, plc Key News
    7.9 Eckert & Ziegler BEBIG
        7.9.1 Eckert & Ziegler BEBIG Corporate Summary
        7.9.2 Eckert & Ziegler BEBIG Business Overview
        7.9.3 Eckert & Ziegler BEBIG Novel Drug Delivery Systems for Cancer Therapy Major Product Offerings
        7.9.4 Eckert & Ziegler BEBIG Novel Drug Delivery Systems for Cancer Therapy Revenue in Global (2016-2021)
        7.9.5 Eckert & Ziegler BEBIG Key News
    7.10 EmboMedics, Inc.
        7.10.1 EmboMedics, Inc. Corporate Summary
        7.10.2 EmboMedics, Inc. Business Overview
        7.10.3 EmboMedics, Inc. Novel Drug Delivery Systems for Cancer Therapy Major Product Offerings
        7.10.4 EmboMedics, Inc. Novel Drug Delivery Systems for Cancer Therapy Revenue in Global (2016-2021)
        7.10.5 EmboMedics, Inc. Key News
    7.11 Kobo Products, Inc.
        7.11.1 Kobo Products, Inc. Corporate Summary
        7.11.2 Kobo Products, Inc. Business Overview
        7.11.3 Kobo Products, Inc. Novel Drug Delivery Systems for Cancer Therapy Major Product Offerings
        7.11.4 Kobo Products, Inc. Novel Drug Delivery Systems for Cancer Therapy Revenue in Global (2016-2021)
        7.11.5 Kobo Products, Inc. Key News
    7.12 Merit Medical Systems, Inc.
        7.12.1 Merit Medical Systems, Inc. Corporate Summary
        7.12.2 Merit Medical Systems, Inc. Business Overview
        7.12.3 Merit Medical Systems, Inc. Novel Drug Delivery Systems for Cancer Therapy Major Product Offerings
        7.12.4 Merit Medical Systems, Inc. Novel Drug Delivery Systems for Cancer Therapy Revenue in Global (2016-2021)
        7.12.5 Merit Medical Systems, Inc. Key News
    7.13 Mo-Sci Corporation
        7.13.1 Mo-Sci Corporation Corporate Summary
        7.13.2 Mo-Sci Corporation Business Overview
        7.13.3 Mo-Sci Corporation Novel Drug Delivery Systems for Cancer Therapy Major Product Offerings
        7.13.4 Mo-Sci Corporation Novel Drug Delivery Systems for Cancer Therapy Revenue in Global (2016-2021)
        7.13.5 Mo-Sci Corporation Key News
    7.14 Nanobiotix
        7.14.1 Nanobiotix Corporate Summary
        7.14.2 Nanobiotix Business Overview
        7.14.3 Nanobiotix Novel Drug Delivery Systems for Cancer Therapy Major Product Offerings
        7.14.4 Nanobiotix Novel Drug Delivery Systems for Cancer Therapy Revenue in Global (2016-2021)
        7.14.5 Nanobiotix Key News
    7.15 Polysciences, Inc.
        7.15.1 Polysciences, Inc. Corporate Summary
        7.15.2 Polysciences, Inc. Business Overview
        7.15.3 Polysciences, Inc. Novel Drug Delivery Systems for Cancer Therapy Major Product Offerings
        7.15.4 Polysciences, Inc. Novel Drug Delivery Systems for Cancer Therapy Revenue in Global (2016-2021)
        7.15.5 Polysciences, Inc. Key News
    7.16 Sirtex Medical, Inc.
        7.16.1 Sirtex Medical, Inc. Corporate Summary
        7.16.2 Sirtex Medical, Inc. Business Overview
        7.16.3 Sirtex Medical, Inc. Novel Drug Delivery Systems for Cancer Therapy Major Product Offerings
        7.16.4 Sirtex Medical, Inc. Novel Drug Delivery Systems for Cancer Therapy Revenue in Global (2016-2021)
        7.16.5 Sirtex Medical, Inc. Key News
    7.17 Terumo Corporation
        7.17.1 Terumo Corporation Corporate Summary
        7.17.2 Terumo Corporation Business Overview
        7.17.3 Terumo Corporation Novel Drug Delivery Systems for Cancer Therapy Major Product Offerings
        7.17.4 Terumo Corporation Novel Drug Delivery Systems for Cancer Therapy Revenue in Global (2016-2021)
        7.17.5 Terumo Corporation Key News
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer


List of Tables and Figures
Ask Sample Report to get more details…

NEED Help?

If you need any help or guidance, please feel free to call us.

USA : +1 (661) 636 6162

INDIA : +91 9325802062

or

Write us on : sales@kandjmarketresearch.com